Hrt Financial LP Cor Medix Inc. Transaction History
Hrt Financial LP
- $20.6 Billion
- Q3 2025
A detailed history of Hrt Financial LP transactions in Cor Medix Inc. stock. As of the latest transaction made, Hrt Financial LP holds 43,840 shares of CRMD stock, worth $497,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,840
Previous 57,043
23.15%
Holding current value
$497,145
Previous $702,000
25.36%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRMD
# of Institutions
204Shares Held
41.2MCall Options Held
1.33MPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA3.98MShares$45.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X03.47MShares$39.4 Million0.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.32MShares$37.7 Million0.74% of portfolio
-
State Street Corp Boston, MA1.84MShares$20.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...